Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma

Exclusion Criteria

• •1. Patients with keratinizing squamous cell carcinoma account for only about 5% of the total pathological types, and the sensitivity of radiotherapy is poor compared with the other two types heterogeneous, so nasopharyngeal carcinoma with pathology of keratinizing squamous cells (WHO type I) is excluded.
• •2. Patients with relapsed and distant metastases.
• •3. The metastatic lymph nodes are located in the target area (Ib zone, the lateral group of the retropharyngeal lymphatic drainage area (VII), and the cervical lymphatic rainage area The medial border moves from top to bottom from the medial border of the common carotid artery to the lateral border, from the annular cartilage to the superior sternal border, sternoclavicular.The triangular area between the anterior and posterior edges of the medial mastoid muscle and the anterior and lateral border of the jugular arteriovenous sheath and lateral border of the thyroid glanddomain).
• •4. Nasopharyngeal primary tumor or retropharyngeal metastatic lymph node invasion of oropharynx.
• •5. Severe heart disease, lung dysfunction, heart function, lung function lower than grade 3 (including grade 3).
• •6. Those whose laboratory test values do not meet the relevant criteria within 7 days before enrollment.
• •7. Those who have participated in clinical trials of other drugs within 3 months before treatment.
• •8. Pregnant or lactating women.
• •9. Patients assessed by investigators to be unable to cooperate with regular follow-up due to psychological, social, family and geographical reasons.